StonvexLoading…
StonvexStonvexStonvexCore line items from NYT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.82B | $2.59B | $2.43B | $2.31B |
Operating Income | $431.56M | $351.10M | $276.27M | $201.97M |
Net Income | $343.98M | $293.82M | $232.39M | $173.91M |
EPS (Diluted) | $2.09 | $1.77 | $1.40 | $1.04 |
Total Assets | $3.00B | $2.84B | $2.71B | $2.53B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $255.44M | $199.45M | $289.47M | $221.38M |
Free Cash Flow OCF − CapEx | $550.50M | $381.34M | $337.95M | $113.73M |
Shares Outstanding | 164.94M | 165.80M | 165.66M | 167.14M |